BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19493584)

  • 21. The usefulness and cost of a shorter duration of fasting in workplace screening for glucose intolerance and metabolic syndrome.
    McLellan RK; Comi RJ; Mackenzie TA; Tilton PA; Dietrich AJ
    Diabetes Res Clin Pract; 2009 Apr; 84(1):e6-8. PubMed ID: 19187998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of metabolic syndrome among middle aged women in Babol, Iran.
    Delavar MA; Lye MS; Khor GL; Hanachi P; Hassan ST
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):612-28. PubMed ID: 19842450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of heart rate on the risk of developing metabolic syndrome.
    Inoue T; Iseki K; Iseki C; Ohya Y; Kinjo K; Takishita S
    Hypertens Res; 2009 Sep; 32(9):801-6. PubMed ID: 19644506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor analysis of the metabolic syndrome components in urban Asian Indian adolescents.
    Vikram NK; Pandey RM; Misra A; Goel K; Gupta N
    Asia Pac J Clin Nutr; 2009; 18(2):293-300. PubMed ID: 19713191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the prevalence of the MS and its complications using three proposed definitions in Korean subjects.
    Sung KC; Kim BJ; Kim BS; Lee WY; Park JB; Wilson AM
    Am J Cardiol; 2009 Jun; 103(12):1732-5. PubMed ID: 19539084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological association between fasting plasma glucose and shortened APTT.
    Lippi G; Franchini M; Targher G; Montagnana M; Salvagno GL; Guidi GC; Favaloro EJ
    Clin Biochem; 2009 Jan; 42(1-2):118-20. PubMed ID: 19014926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic strategy to improve the efficiency of screening diabetes--ROC analysis for fasting plasma glucose.
    Lu J; Jia W; Chen L; Wu Y; Zuo Y; Xiang K
    Diabetes Res Clin Pract; 2008 Jun; 80(3):e14-5. PubMed ID: 18423771
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Schneiderhan ME; Batscha CL; Rosen C
    Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An accurate risk score for estimation 5-year risk of type 2 diabetes based on a health screening population in Taiwan.
    Sun F; Tao Q; Zhan S
    Diabetes Res Clin Pract; 2009 Aug; 85(2):228-34. PubMed ID: 19500871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes, impaired fasting glucose, and their association with increased hepatic enzyme levels among the employees in a university hospital in Thailand.
    Jiamjarasrangsi W; Lertmaharit S; Sangwatanaroj S; Lohsoonthorn V
    J Med Assoc Thai; 2009 Jul; 92(7):961-8. PubMed ID: 19626817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron supplementation and gestational diabetes in midpregnancy.
    Bo S; Menato G; Villois P; Gambino R; Cassader M; Cotrino I; Cavallo-Perin P
    Am J Obstet Gynecol; 2009 Aug; 201(2):158.e1-6. PubMed ID: 19527900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Uric acid predicts type 2 diabetes mellitus in the general population].
    Cardona F; Rojo-Martínez G; de la Cruz Almaraz M; Soriguer F; García-Fuentes E; Tinahones FJ
    Endocrinol Nutr; 2009 Feb; 56(2):66-70. PubMed ID: 19627714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
    Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resectability of pancreatic cancer and diabetes.
    Yang F; Fu D; Ni Q
    Am J Gastroenterol; 2008 Apr; 103(4):1043; author reply 1043-4. PubMed ID: 18397427
    [No Abstract]   [Full Text] [Related]  

  • 35. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower vital capacity is associated with diabetes but not with metabolic syndrome in nonobese Japanese men.
    Oda E; Kawai R
    Diabetes Care; 2009 Jun; 32(6):e69. PubMed ID: 19460905
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors of the development of impaired fasting glucose versus impaired glucose tolerance are partly different in men: a 6-year follow-up study.
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabetologia; 2004 Mar; 47(3):590-592. PubMed ID: 14749845
    [No Abstract]   [Full Text] [Related]  

  • 38. [Follow-up in diabetes. This "minimal program" should be followed].
    Gain T
    MMW Fortschr Med; 2001 Mar; 143(9):41-3. PubMed ID: 11288532
    [No Abstract]   [Full Text] [Related]  

  • 39. Male pelvic health: a urological call to arms.
    Kaplan SA
    J Urol; 2006 Dec; 176(6 Pt 1):2351-2. PubMed ID: 17085100
    [No Abstract]   [Full Text] [Related]  

  • 40. Underweight as a predictor of diabetes in older adults: a large cohort study.
    Sairenchi T; Iso H; Irie F; Fukasawa N; Ota H; Muto T
    Diabetes Care; 2008 Mar; 31(3):583-4. PubMed ID: 18071003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.